In a phase 2 clinical study, patients who were administered 20 mg/day lorcaserin attained an average weight loss of 3.6 kg, which was significantly greater than the average weight loss of 0.3 kg in the placebo group [82]
For optimal results, we typically combine B12 injections with other evidence-based SAD interventions such as light therapy and appropriate physical activity
When a compound has no completed human trial, there is by definition no safety data in any subgroup no pregnancy data, no hepatic-impairment data, no interaction data with common metabolic or endocrine medications
Those trials examined its effect on body weight and fat mass in adults with obesity
The compounds research profile now spans adipose tissue biology, skeletal muscle physiology, gut microbiome modulation, cardiovascular metabolic pathways, and cancer cell biology
For those with a personal or family history of diabetes, high blood pressure, blood vessel disease, or high blood sugar, semaglutide treatment should always be monitored by a qualified medical professional
